Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-180-5 | CAS number: 79-14-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- IN-LIFE DATES: From: August 13, 1998 To: September 9, 1998
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Guideline and GLP-compliant regulatory study. Study report revised in 2010 to re-calculate the LD50 value following re-evaluation of mortality data.
Data source
Referenceopen allclose all
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 998
- Report date:
- 1998
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 010
- Report date:
- 2010
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- EPA OPP 81-1 (Acute Oral Toxicity)
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- Glycollic acid
- EC Number:
- 201-180-5
- EC Name:
- Glycollic acid
- Cas Number:
- 79-14-1
- Molecular formula:
- C2H4O3
- IUPAC Name:
- 2-hydroxyacetic acid
- Details on test material:
- Glycolic acid 70% solution
Constituent 1
Test animals
- Species:
- rat
- Strain:
- other: Crl:CD (SD) IGS BR rats
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Source of rats was Charles River Laboratories, Raleigh, North Carolina, USA. Male rats were 57 or 58 days old in a body weight range of 239.5 – 267.0 g. Female rats were 78 or 79 days old in a body weight range of 203.8 – 242.9 g prior to fasting overnight from day -1 to day of dosing.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- Individual doses were adjusted to take account of animal’s fasted bodyweight and the specific gravity of the test material (1.25 g/mL) to achieve the dose levels. Additionally, the doses were adjusted for purity. The rats were fasted overnight (approximately 18 hours) prior to dosing. Post exposure period was 14 days.
- Doses:
- 1000, 2000 and 3000 mg/kg as a 70% aqueous solution
- maximum administered dose volume was 3.40 ml/kg bw - No. of animals per sex per dose:
- TEST ANIMALS
- Source: Charles River Laboratories, Inc., Raleigh, North Carolina.
- Age at study initiation: Male rats were 57 or 58 days old and female rats were 78 or 79 days old on day of dosing.
- Weight at study initiation: Average fasting body weights were between 224 g and 234.5 g for males and between 207.1 g
and 213.5 g for females.
- Fasting period before study: Approximately 18 hours prior to dosing. Food was returned within approximately 3 hours
after dosing.
- Housing: Rats were housed singly in suspended, stainless steel, wire-mesh cages.
- Diet (e.g. ad libitum): PMI Nutrition International, Inc. Certified Rodent LabDiet 5002 ad libitum.
- Water (e.g. ad libitum): Ad libitum.
- Acclimation period: Rats were quarantined, weighed and observed for general health for 6 days.
- 10 (5 male and 5 female) per dose group
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 23 +/- 1°C.
- Humidity (%): 50+/- 10%.
- Photoperiod (hrs dark / hrs light): Timer controlled (12-hour light/12-hour dark cycle) lighting. - Control animals:
- no
- Details on study design:
- Daily observations (weekends and holidays excluded unless warranted by the condition of the rats) of mortality, clinical observations of toxicity or behavioural change and body weights. All rats found dead or sacrificed were necropsied.
- Duration of observation period following administration: 14 days.
- Frequency of observations and weighing: Observations for mortality, signs of illness, injury or abnormal behavior were made daily. Rats were weighed and observed for clinical signs of toxicity daily (weekends and holday excluded unless warranted by the condition of the rats).
- Necropsy of survivors performed: Yes.
- Other examinations performed: Clinical signs, body weight, mortality, gross observations
Statistics
Average fasting body weight, LD50 95% confidence interval, mortality ratio (deaths/exposed). - Statistics:
- Method of determination of LD50 was calculated by probit analysis (Finney, D. J., Probit Analysis, 1971).
Results and discussion
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 2 040 mg/kg bw
- 95% CL:
- 1 443 - 2 469
- Remarks on result:
- other: LD50 recalculated in revised report to address death of one intermediate dose female that died following apparent dosing trauma. The LD50 was based on 100% glycolic acid dosed (adjusted for 70% purity of the test substance).
- Mortality:
- Mortalities at the 1000, 2000 and 3000 mg/kg dose levels were 0, 50 and 90%, respectively. Mortalities occurred up to four days after dosing. One female dosed at 2000 mg/kg bw died following apparent dosing trauma. Since the death was not directly attributable to an effect of glycolic acid this data was excluded from the calculation of the median lethal dose when the study report was revised in 2010.
- Clinical signs:
- other: other: Clinical signs observed included lethargy, lung noise, ocular discharge, prostrate posture, hunched posture, stained face or chin, clear oral discharge, bloating, pallor, inappetance and moribundity.
- Gross pathology:
- Black stomach discolouration was observed in 5 male rats at 3000 mg/kg and 1 and 4 female rats at 2000 and 3000 mg/kg, respectively. Most rats exhibiting stomach discolouration also had stomachs distended with black fluid. Brown lung discolouration, possibly due to a gavage accident, was observed in one female rat at 2000 mg/kg - the death of this rat was attributed to mal-administration rather than a result of systemic toxicity. The gross observations for the other male and female rats were non-specific and not indicative of target organ toxicity.
- Other findings:
- No further information.
Any other information on results incl. tables
Table Study summary |
|||||||
Group |
Dose level (mg/kg) |
Average dose volume (mL) |
Mean bodyweight (g) |
% mortality |
|||
Day 11 |
Day 7 |
Day 15 |
|
||||
Male |
1000 |
0.26 |
224 |
277.6 |
338.5 |
0 |
|
Female |
0.24 |
208.7 |
240.3 |
258.2 |
0 |
||
Male |
2000 |
0.53 |
234.5 |
239.7 |
321.8 |
40 |
|
Female |
0.47 |
207.1 |
224.62 |
2622 |
80 |
||
Male |
3000 |
0.78 |
229.8 |
na |
na |
100 |
|
Female |
0.72 |
213.5 |
243.92 |
271.12 |
80 |
||
LD50value |
2040 mg/kg bw |
|
|||||
1= fasted body weight |
|
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Fasted male and female rats were dosed at 1000, 2000 and 3000 mg/kg by oral gavage administration of the test material, glycolic acid 70% solution. Clinical signs and body weights were observed over 14 days post-dose and all animals were subjected to a necropsy. Mortalities in the treatment groups were 0, 50 and 90% for the 1000, 2000 and 3000 mg/kg doses, respectively. Clinical signs observed included lethargy, lung noise, ocular discharge, prostrate posture, hunched posture, stained face or chin, clear oral discharge, bloating, pallor and moribundity. There were few signs among rats dosed at 1000 mg/kg and the primary effects at 3000 mg/kg were prostration and lethargy. The majority of decedents were found dead on day 2, with isolated deaths occurring on days 1, 3 or 4. LD50(male and female rates combined) – 2040 mg/kg (95% confidence limits of 1443 to 2469 mg/kg).
- Executive summary:
Fasted male and female rats were dosed at 1000, 2000 and 3000 mg/kg by oral gavage administration of the test material, glycolic acid 70% solution. Clinical signs and body weights were observed over 14 days post-dose and all animals were subjected to a necropsy.
Mortalities in the treatment groups were 0, 50 and 90% for the 1000, 2000 and 3000 mg/kg doses, respectively. Clinical signs observed included lethargy, lung noise, ocular discharge, prostrate posture, hunched posture, stained face or chin, clear oral discharge, bloating, pallor and moribundity. There were few signs among rats dosed at 1000 mg/kg and the primary effects at 3000 mg/kg were prostration and lethargy. The majority of decedents were found dead on day 2, with isolated deaths occurring on days 1, 3 or 4. LD50 (male and female rates combined) – 2040 mg/kg (95% confidence limits of 1443 to 2469 mg/kg).
Under the conditions of this test, the oral LD50 of Glycolic Acid for male and female rats combined was 2040 mg/kg with 95% confidence limits of 1443 - 2469 mg/kg. No classification of Glycolic acid is necessary on basis of the oral acute median lethal dose in rats.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.